Proposals to include biologics in price controls could threaten NHS savings, says biosimilars head

Government proposals to include all biologics within the scope of price-controlled health service medicines could impact patient benefit and threaten NHS England ’s savings target, the director general of the British Generic Manufacturers Association and the British Biosimilars Association has warned.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research